Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript February 15, 2024
Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-1.82, expectations were $-2.04. Blueprint Medicines Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good morning. My name is Jerin and I will be your conference operator today. At this time, I would like to welcome everyone to the...
